Sage Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
60%
€44.20
Target price
31.12.25
€60.00
Performance (%)
-73.91%
Price
08.05.24
€11.53
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Sage Therapeutics Inc. is performing very badly with a performance of -73.91%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sage Therapeutics Inc. | -5.608% | -5.608% |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
According to BiotechBee what are the pros and cons of Sage Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Buy mit Kursziel 60,0